Intermittent preventive therapy for malaria with monthly artemether–lumefantrine for the post-discharge management of severe anaemia in children aged 4–59 months in southern Malawi: a multicentre, randomised, placebo-controlled trial
Reference:
The Lancet Infectious Diseases, Volume 12, Issue 3, March 2012, Pages 191-200
We aimed to assess whether 3 months of chemoprevention with artemether–lumefantrine reduced this risk.
Person:
Country:
Medical Condition:
Medical Treatment:
